quantrifat

RGEN

看多
quantrifat 已更新   
NASDAQ:RGEN   Repligen Corporation
First Half 2019 Highlights--
Revenue increased by 42% year-over-year, and 42% organically, to $131.3 million
GAAP income from operations increased 580 bps to 16.9% of revenue
Adjusted (non-GAAP) income from operations increased 870 bps to 27.2% of revenue
GAAP fully-diluted EPS increased to $0.34 compared to $0.14 for the first half of 2018

Adjusted (non-GAAP) fully-diluted EPS increased to $0.59 compared to $0.29 for the first half of 2018

Buy Zone: $81.45 to $77.96
Stop loss: Daily close below $76.70
Target: $99+
交易進行:
adjust the stop loss::-- daily close below $77.33 area.
交易進行:
sorry for the typing error... stop loss is daily close below 76.33 area
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。